Parapharyngeal liposarcoma: A case report

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Li, Hong ^a   Zhou, Xueqin ^a   Ran, Qian ^a   Wang, Liuqian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CASE REPORT; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHARYNX CANCER; PREDICTIVE VALUE; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; PHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84874585906     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-42     Document Type: Article

References (12)

1. Rogers J, Patil Y, Strickland-Marmol L, et al. Lipomatous tumors of the parapharyngeal space: case series and literature review. Arch Otolaryngol Head Neck Surg 2010, 136:621-624. 10.1001/archoto.2010.93, 20566915.
2. Brcić L, Jakovcević A, Vuletić LB, Orlić D, Seiwerth S. Pleomorphic liposarcoma of the foot: a case report. Diagn Pathol 2008, 3:15. 10.1186/1746-1596-3-15, 2358876, 18416844.
3. Armah HB, Yin M, Rao UN, Parwani AV. Angiomyolipoma with epithelial cysts (AMLEC): a rare but distinct variant of angiomyolipoma. Diagn Pathol 2007, 2:11. 10.1186/1746-1596-2-11, 1845137, 17376246.
4. Bour-Jordan H, Esensten JH, Martinez-Llordella M, et al. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev 2011, 241:180-205. 10.1111/j.1600-065X.2011.01011.x, 3077803, 21488898.
5. Hwang I, Ki D. Receptor-mediated T cell absorption of antigen presenting cell-derived molecules. Front Biosci 2011, 16:411-421. 10.2741/3695, 3057749, 21196178.
6. Seliger B, Quandt D. The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother 2012, 61:1327-1341. 10.1007/s00262-012-1293-6, 22695874.
7. Capece D, Verzella D, Fischietti M, et al. Targeting costimulatory molecules to improve antitumor immunity. J Biomed Biotechnol 2012, 2012:926321. 3303883, 22500111.
8. Freeman GJ, Casasnovas JM, Umetsu DT, et al. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010, 235:172-189. 2914464, 20536563.
9. Anderson AC. Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 2012, 24:213-216. 10.1016/j.coi.2011.12.005, 22226204.
10. Weber J. Immune checkpoint proteins: a new therapeutic paradigm for cancer-preclinical background: CTLA-4 and PD-1 blockade. Semin Oncol 2010, 37:430-439. 10.1053/j.seminoncol.2010.09.005, 21074057.
11. Sakuishi K, Jayaraman P, Behar SM, et al. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2011, 32:345-349. 10.1016/j.it.2011.05.003, 3164311, 21697013.
12. Chiba S, Baghdadi M, Akiba H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012, 13:832-842. 10.1038/ni.2376, 22842346.